FZMD vs ABT: Which Stock is Better?
Side-by-side comparison of Fuse Medical Inc and Abbott Laboratories in 2026
FZMD
Fuse Medical Inc
—
ABT
Abbott Laboratories
$95.63
Key Metrics Comparison
| Metric | FZMD | ABT | Winner |
|---|---|---|---|
| Market Cap | $5.17M | $154.15B | ABT |
| P/E Ratio | 1.40 | 24.79 | FZMD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze FZMD
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is FZMD or ABT a better investment?
Comparing FZMD and ABT: Fuse Medical Inc has a market cap of $5.17M while Abbott Laboratories has $154.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between FZMD and ABT?
FZMD (Fuse Medical Inc) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: FZMD or ABT?
Based on P/E ratios, FZMD trades at a lower multiple (1.4x vs 24.8x).
Which is growing faster: FZMD or ABT?
Both FZMD and ABT show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: FZMD or ABT?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: FZMD or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $154.15B compared to $5.17M for FZMD.
Should I buy FZMD or ABT in 2026?
Both FZMD and ABT have investment merit. FZMD trades at $N/A while ABT trades at $95.63. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between FZMD and ABT stock?
Key differences: Market Cap ($5.17M vs $154.15B), P/E Ratio (1.4x vs 24.8x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy FZMD or ABT in 2026?
The choice between FZMD and ABT depends on your investment goals. ABT shows higher revenue growth (0.0%). ABT has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between FZMD and ABT?
FZMD (Fuse Medical Inc) has a market cap of $5.17M, while ABT (Abbott Laboratories) has a market cap of $154.15B. ABT is the larger company by market value.